Regulus Therapeutics Inc (NASDAQ:RGLS)

0.6406
Delayed Data
As of 3:59pm ET
 -0.0084 / -1.29%
Today’s Change
0.63
Today|||52-Week Range
1.95
-38.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-56.7M-55.7M-81.8M-71.9M
 
 
 
 
 
Depreciation1.5M1.6M2.3M2.5M
 
 
 
 
 
Total Other Cash Flow20.8M18.7M14.6M8.6M
 
 
 
 
 
Funds From Operations-34.4M-35.4M-65.0M-60.8M
 
 
 
 
 
Funds From/For Other Operating Expenses5.1M14.5M-8.1M-2.0M
 
 
 
 
 
Net Cash Flow - Operating Activities-39.5M-49.9M-56.9M-58.8M
 
 
 
 
 
 
InvestingIncrease In Investments-113.4M-78.4M-65.1M-55.7M
 
 
 
 
 
Decrease In Investments85.4M101.3M101.4M69.9M
 
 
 
 
 
Capital Expenditures-1.1M-1.4M-913.0K-303.0K
 
 
 
 
 
Net Cash Flow Investing-29.2M21.5M35.3M13.9M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings0.000.0019.8M0.00
 
 
Long Term Debt Reduction-142.0K-155.0K--0.00
 
 
 
Net Proceeds Stock Sale88.4M7.2M951.0K43.4M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.00----0.00--
Cash Dividends Paid - Total0.00----0.00--
Other Sources - Financing0.000.00--0.00--
Other Uses - Financing0.000.00167.0K0.00
 
 
Net Cash Flow - Financing88.2M7.0M20.6M43.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash19.5M-21.4M-1.0M-1.4M